New Glycoside Derivatives of 6H-Indolo{2,3-b]quinolines

• Autorzy: Badowska-Rosłonek K. , Kaczmarek Ł. , Ramza J. , Godlewska J. , Opolski A. , Peczyńska-Czach W.
• Języki publikacji: EN

Abstrakty

EN

The series of carbohydrate derivatives of 6H-indolo[2,3-b]quinoline was obtained. Carbohydrate units (2-deoxy-D-glucose, 2-deoxy-D-lactose and 2-deoxy-L-rhamnose) were coupled viaa glycosidic bond to a hydroxyl group placed in a side chain at selected positions of indoloquinoline. Increased solubility was noted for all obtained products. Some of them exhibit also increased in vitro cytotoxicity.

Słowa kluczowe

EN

glycosides of 6H-indolo[2,3-b]quinolines; cytotoxicity

• Wydawca: Polskie Towarzystwo Chemiczne
• Czasopismo: Polish Journal of Chemistry
• Rocznik: 2005
• Tom: Vol. 79 / nr 2
• Strony: 369--386
• Opis fizyczny: Bibliogr. poz. 17, rys.

Twórcy

autor

Badowska-Rosłonek K.

• Pharmaceutical Research Institute, ul. Rydygiera 8, 01-793 Warszawa, Poland

autor

Kaczmarek Ł.

• Pharmaceutical Research Institute, ul. Rydygiera 8, 01-793 Warszawa, Poland

autor

Ramza J.

• Pharmaceutical Research Institute, ul. Rydygiera 8, 01-793 Warszawa, Poland

autor

Godlewska J.

• Institute of Immunology and Experimental Therapy, PAS, ul. Weigla 12, 53-114 Wrocław, Poland

autor

Opolski A.

• Institute of Immunology and Experimental Therapy, PAS, ul. Weigla 12, 53-114 Wrocław, Poland

autor

Peczyńska-Czach W.

• Institute of Organic Chemistry, Biochemistry and Biotechnology, Wrocław University of Technology, Wybrzeże Wyspiañskiego 27, 50-370 Wrocław, Poland

Bibliografia

• 1. Sufness M. and Cordell G.A., The alkaloids, 1985, 25, 89-141, Academic Press, N. York; Goodwin S., Smith A.F. and Homing E.C., J. Am. Chem. Soc., 81, 1903 (1959); Kohn K.W., Ross W.E. and Glaubiger D., Antibiotics (V), 1979, Part 2, (ed. Hahn F.E.), Springer-Verlag, Berlin; Hewlins M.J.E., Oliveira-Campus A.M. and Shannon P.V.R., .Synthesis, 4, 289 (1984).
• 2.Nettelton D.E., Doyle T.W., Krishnan B., Matsumoto G.K. and Clardy J., Tetrahedron Lett., 26, 4011 (1985); Yamashim Y., Fujii N., Murakata C., Ashizawa T., Okabe M. and Nakano H., Biochemistry, 31(48), 12069 (1992); Anizon P., Belin L., Moreau P., Sancelme M., Voldoire A., Prudhomme M., Ollier M., Severe D., Riou J-F., Bailly C., Fabbro D. and Meyer T., J Med Chem., 40, 3456 (1997).
• 3. Omura S., Iwai Y., Hirano A., Nakagawa A., Awaya J., Tsuchiya H., Takahashi Y. and Masuma R., J. Antibion, 30, 275 (1977); Furusaki A., Hashiba N., Matsumoto T., Hirano A., Iwai Y. and Omura S., Bull. Chem. Soc. Jpn., 55, 3681 (1982); Gribble G. and S. Berthel S.; “Studies in Natural Products Chemistry.”, Elsevier Science Publishers; New York, vol. 12, 365, 1993; Omura S., Sasaki Y., Iwai Y. and Takeshima H., .J. Antibiot., 48, 535 (1995).
• 4. Bonjouklian R.,,Smitka T.A., Doolin L.E., Molloy R.M., Debono M., Shaffer S.A., Moore R.E., Stewart J.B. and Patterson G.M.L., Tetrahedron, 47, 7739 (1991); Osada H., Satake M. I., Koshino H., Onose R. and Isono K., J. Antibiot., 45, 27s (1992).
• 5. Pognan F., Saucier J.M., Paoletti C., Kaczmarek L., Nantka-Namirski P., Mordarski M. and Peczyńska-Czoch W., Biochem. Pharm., 44, 2149 (1992); Peczyńska-Czoch W., Pognan F., Kaczmarek L. and Boratyński J., .J. Med. Chem., 31, 3503 (1994).
• 6. Cimanga K., De Bruyne T., Pieters L., Claeys M. and Vietinck A., Tetrahedron Lett., 37, 1703 (1996); Dassonneville L., Lansiaux A., Wattelet A., Wattez N., Mahieu C., Miert S., Pieters L. and Bailly C., Eur. J. PharmacoI., 409, 9 (2000).
• 7. Zou Y., Ling Y., Van N. T., Priebe W. and Perez-Solar R., Cancer Research, 54, 1479 ( 1994); Priebe W., Booser D. and Perez-Solar R., Cell. Mol. Biol. Lett., 4, 247 (1999).
• 8. Rodrigues-Pereira E., Belin L., Sancelme M., Prudhomme M., Ollier M.., Rapp M., Servcre D., Riou .l.F. and Fabbro D., .J. Med. Chem., 39, 4471 (1996); Bailly C., Riou J. F., Colson P., Houssier C., Rodrigues-Pereira E. and Prudhomme M.,Biochemist1y, 36, 3917 (1997); ShankarB. B. and McCombic S.W., TetrahedronLett., 35, 3005 (1994); Chisholm J.D. and Van Vranken D.L.,J. Org. Chem., 65, 8406 (2000). [Erratum for Vol. 65, 2000].
• 9. Honda T., Kato M., Inoue M., Shimamoto T., Shima K., Nakanishi T., Yoshida T. and Noguchi T., J. Med. Chem., 31, 1295 (1988).
• 10. Link J.T., Raghavan S., Gallant M., Danishefsky S.J., Chou T.C. and Ballas L.M., J. Am. Chem. Soc.,118, 2825 (1996); Ohkubo M., Nishimura T., Jona H., Honma T. and Morishima H., Tetrahedron, 52, 8099 (1996); Gallant M., Link J.T. and Danishefsky S.J., J. Org. Chem., 58, 343 (1993).
• 11.Bolit V. and Mioskowski J., J. Org. Chem., 55, 5812 (1990).
• 12. Campbell K.., Tipson R.S., Elderfield R.C., Campbell B.K., Clapp M.A., Gensler W.J., Morrison D. and Moron W.J., J. Org. Chem., 11, 803 (1946); Lauer W.M. and Koslow C.E., “4-Methylcarbostyryl'‘, Org. Synth. CoII., Vol. 3, 580-581, Hornig Ed., J. Wiley 8: Sons Inc., N. York 1955; Koslow C.E. and Laue: W.M., “2-Chlorolepidine‘, Org. Synth CoIl., Vol. 3, 194-195, Homig Ed., J. Wiley & Sons Inc.,N. York 1955; Kaczmarek L., Poczynska-Czoch W., Osiadacz J., Mordarski M., Sokalski A.W., Boratynski J., Marcinkowska E., Glazman-Kuśnierczyk I-I. and Radzikowski C., Bioorg. Med. Chem., 7, 2457 (1999).
• 13 . Kaczmarek L., Badowska-Roslonck K., Ramm J ., Szelejewski W., Godlewska J. and Peczynska-Czoch W., Polish Patent Application # P-353811, Warszawa 2002.
• 14. Vogel A.I., “Preparatyka Organiczna", 1984, WNT Warszawa (in Polish).
• 15. Mąkosza M., “Synteza Organiczna”, 1972, PWN Warszawa (in Polish).
• 16. Skehan P., Storeng R. and Scudiero D., J Natl. Cancer. Inst., 82, 1107 (1990).
• 17. Badowska-Roslonek K., PhD Thesis, Department of Pharmacy, Warsaw Medical University, Warszawa 2004. .